Commonwealth Equity Services LLC Increases Position in Cigna Group $CI

Commonwealth Equity Services LLC grew its position in shares of Cigna Group (NYSE:CI) by 8.8% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 122,055 shares of the health services provider’s stock after purchasing an additional 9,910 shares during the period. Commonwealth Equity Services LLC’s holdings in Cigna Group were worth $35,182,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Asset Management One Co. Ltd. lifted its stake in Cigna Group by 4.6% during the 3rd quarter. Asset Management One Co. Ltd. now owns 118,161 shares of the health services provider’s stock worth $34,060,000 after acquiring an additional 5,184 shares in the last quarter. 4J Wealth Management LLC increased its stake in Cigna Group by 6.6% during the third quarter. 4J Wealth Management LLC now owns 732 shares of the health services provider’s stock worth $211,000 after purchasing an additional 45 shares during the period. Trust Co. of Oklahoma lifted its position in shares of Cigna Group by 3.2% during the third quarter. Trust Co. of Oklahoma now owns 4,906 shares of the health services provider’s stock worth $1,414,000 after purchasing an additional 152 shares in the last quarter. Gateway Investment Advisers LLC boosted its stake in shares of Cigna Group by 3.6% in the third quarter. Gateway Investment Advisers LLC now owns 20,795 shares of the health services provider’s stock valued at $5,994,000 after purchasing an additional 718 shares during the period. Finally, Fifth Third Wealth Advisors LLC grew its holdings in shares of Cigna Group by 72.4% in the third quarter. Fifth Third Wealth Advisors LLC now owns 2,800 shares of the health services provider’s stock valued at $807,000 after purchasing an additional 1,176 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO David Cordani purchased 4,134 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the purchase, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.70% of the stock is owned by corporate insiders.

Cigna Group Trading Down 2.0%

NYSE:CI opened at $279.05 on Thursday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The stock has a market cap of $74.54 billion, a P/E ratio of 12.31, a P/E/G ratio of 1.00 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a 50-day simple moving average of $270.88 and a 200-day simple moving average of $289.43.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Thursday, December 4th were given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Cowen set a $333.00 price target on shares of Cigna Group in a research report on Monday, December 15th. Robert W. Baird reduced their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Wells Fargo & Company lowered their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 5th. Sanford C. Bernstein restated a “market perform” rating and set a $307.00 price target on shares of Cigna Group in a report on Tuesday. Finally, The Goldman Sachs Group decreased their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $333.04.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.